Press Releases

Press Releases

All Releases
View Summary Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
May 8, 2013
PDF 10.3 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
May 2, 2013
PDF 25.8 KB Add to Briefcase
View Summary Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
Apr 25, 2013
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
Mar 14, 2013
PDF 10.8 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Announces the Availability of OFIRMEV® (acetaminophen) Injection through the VA National Formulary
Mar 12, 2013
PDF 12.7 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
Mar 7, 2013
PDF 28.4 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV® (acetaminophen) Injection
Mar 6, 2013
PDF 19.2 KB Add to Briefcase
View Summary Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
Feb 28, 2013
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
Feb 26, 2013
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
Feb 6, 2013
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
Jan 23, 2013
PDF 14.6 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
Dec 12, 2012
PDF 13.8 KB Add to Briefcase
View Summary Cadence Pharmaceuticals to Host Analyst and Investor Day
Nov 28, 2012
PDF 13.4 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Announces Settlement of OFIRMEV® (Acetaminophen) Injection Patent Litigation with Perrigo Company
Nov 28, 2012
PDF 16.4 KB Add to Briefcase
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
Nov 21, 2012
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Nov 5, 2012
PDF 24.6 KB Add to Briefcase
View Summary Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
Oct 29, 2012
PDF 10.0 KB Add to Briefcase
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
Aug 29, 2012
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
Aug 10, 2012
PDF 9.9 KB Add to Briefcase
View Summary Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
Aug 2, 2012
PDF 25.2 KB Add to Briefcase
Showing 1-20 of 171 Page: 1 2 3 4 5 ... 9  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote
CADX - (NASDAQ)
$6.70   - 0.29
May 22, 2013
4:00 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.